California, led by Democratic governor Gavin Newsom, has decided to break with the federal positions on public health and has resolved to stand by policies backed by science rather than the controversial positions being taken by the federal government through its health secretary R. F. Kennedy Jr.
Many see the policies being pushed by the federal administration as misinformation and politicization of matters that should entirely be based on rigorous science. For example, Kennedy has linked autism to vaccination despite the lack of solid scientific data backing such a claim. Policy decisions like changing vaccine mandates have been seen as taking the country backwards from the public health successes it had scored in past decades when vaccination mandates helped to prevent or control various diseases like measles.
Federal funding cuts to the health sector, including slashing funding available to the CDC and laying off thousands of employees at federal health agencies, have caused alarm as such actions threaten the very foundations of the systems that have helped to protect public health across the country.
Newsom has been outspoken against these moves and has taken steps that clearly break with the federal position. For example, while the U.S. was declared measles-free in 2000, the country is at risk of losing that status after 2,281 cases of the disease were confirmed last year, with more than 90% of these cases occurring among people who weren’t vaccinated or their vaccination status couldn’t be confirmed.
Newsom has countered such policy decisions by signing a law allowing California to issue its own vaccine guidance even if such guidance isn’t in line with federal guidelines. This law requires health insurance firms to cover such vaccinations that don’t align with the guidance provided by the federal government.
When Trump canceled about $600 billion in federal health grants to Minnesota, Colorado, Illinois and California, all blue states, Newsom led an effort in which those states sued the federal government. A judge has issued a temporary injunction blocking the federal government from implementing those funding cuts until the case is resolved.
When Susan Monarez was fired by Kennedy from her position as CDC director because she resisted efforts to “politicize science,” Newsom immediately hired her to spearhead efforts to modernize public health in California.
Additionally, when Trump withdrew the U.S. from the World Health Organization, Newsom responded by making California join a WHO-led global network focused on responding to disease outbreaks. California was the first U.S. state to join this body, and several others, including Colorado, New York, Illinois and Wisconsin followed suit.
As this dogfight between Newsom and the federal government gathers momentum, entities like Astiva Health that provide health cover to underserved communities, such as racial minorities, in California are likely to have a tougher job on their hands as state leaders clash with federal government positions on matters of public health.
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
